Advances in stroke neuroprotection: hyperoxia and beyond.
暂无分享,去创建一个
Turgay Dalkara | M. Moskowitz | E. Lo | A. Singhal | T. Dalkara | Aneesh B Singhal | Eng H Lo | Michael A Moskowitz
[1] F. Buonanno,et al. A pilot study of drug-induced hypertension for treatment of acute stroke , 2001, Neurology.
[2] F. Cheng,et al. Effects of magnesium sulfate on energy metabolites and glutamate in the cortex during focal cerebral ischemia and reperfusion in the gerbil monitored by a dual-probe microdialysis technique. , 2002, Life sciences.
[3] V. Perry,et al. Monocyte Chemoattractant Protein-1 Deficiency is Protective in a Murine Stroke Model , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[4] P. Chan. Reactive Oxygen Radicals in Signaling and Damage in the Ischemic Brain , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[5] S. Warach. New imaging strategies for patient selection for thrombolytic and neuroprotective therapies , 2001, Neurology.
[6] L. Nowak,et al. Magnesium gates glutamate-activated channels in mouse central neurones , 1984, Nature.
[7] E. Lo,et al. Involvement of Matrix Metalloproteinase in Thrombolysis-Associated Hemorrhagic Transformation After Embolic Focal Ischemia in Rats , 2002, Stroke.
[8] Mathias Hoehn-Berlage,et al. Potassium-Induced Cortical Spreading Depressions during Focal Cerebral Ischemia in Rats: Contribution to Lesion Growth Assessed by Diffusion-Weighted NMR and Biochemical Imaging , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[9] B R Rosen,et al. Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time. , 1999, Radiology.
[10] K. Rajamani,et al. Stroke precipitated by moderate blood pressure reduction. , 2000, The Journal of emergency medicine.
[11] J. Grotta,et al. Lubeluzole in Acute Ischemic Stroke Treatment: A Double-Blind Study With an 8-Hour Inclusion Window Comparing a 10-mg Daily Dose of Lubeluzole With Placebo , 2000, Stroke.
[12] G. Feuerstein,et al. Breathing 100% oxygen after global brain ischemia in Mongolian Gerbils results in increased lipid peroxidation and increased mortality. , 1987, Stroke.
[13] R. Busto,et al. Human Albumin Therapy of Acute Ischemic Stroke: Marked Neuroprotective Efficacy at Moderate Doses and With a Broad Therapeutic Window , 2001, Stroke.
[14] D. Holtzman,et al. Selective, Reversible Caspase-3 Inhibitor Is Neuroprotective and Reveals Distinct Pathways of Cell Death after Neonatal Hypoxic-ischemic Brain Injury* , 2002, The Journal of Biological Chemistry.
[15] Yi Li,et al. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke , 2003, Annals of neurology.
[16] G. Hankey,et al. Clomethiazole Acute Stroke Study in Ischemic Stroke (CLASS-I): Final Results , 2002, Stroke.
[17] Marcel Leist,et al. Four deaths and a funeral: from caspases to alternative mechanisms , 2001, Nature Reviews Molecular Cell Biology.
[18] D. Krieger,et al. Therapeutic Hypothermia for Acute Ischemic Stroke: What Do Laboratory Studies Teach Us? , 2004, Stroke.
[19] Guo-Yuan Yang,et al. Reduced Ischemic Brain Injury in Interleukin-1β Converting Enzyme—Deficient Mice , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[20] Christopher Putman,et al. Utility of Perfusion-Weighted CT Imaging in Acute Middle Cerebral Artery Stroke Treated With Intra-Arterial Thrombolysis:: Prediction of Final Infarct Volume and Clinical Outcome , 2001, Stroke.
[21] Tao Yang,et al. Glycoprotein IIb/IIIa Antagonist, Murine 7E3 F(ab′)2, and Tissue Plasminogen Activator in Focal Ischemia: Evaluation of Efficacy and Risk of Hemorrhage with Combination Therapy , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[22] H. Fukasawa,et al. Therapeutic effects of hyperbaric oxygenation on acute focal cerebral ischemia in rats. , 1990, Surgical neurology.
[23] B. Meldrum,et al. Factors influencing the frequency of fluorescence transients as markers of peri-infarct depolarizations in focal cerebral ischemia. , 2000, Stroke.
[24] D. Choi,et al. Additive neuroprotective effects of dextrorphan and cycloheximide in rats subjected to transient focal cerebral ischemia , 1996, Brain Research.
[25] F. Welsh,et al. Postischemic Hypothermia Fails to Reduce Ischemic Injury in Gerbil Hippocampus , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[26] H. Weiss,et al. Effects of magnesium sulfate and nifedipine on regional cerebral blood flow during middle cerebral artery ligation in the rat. , 1990, Archives internationales de pharmacodynamie et de therapie.
[27] D. Liebeskind,et al. Trends in Acute Ischemic Stroke Trials Through the 20th Century , 2001, Stroke.
[28] J. Ulatowski,et al. A Pilot Randomized Trial of Induced Blood Pressure Elevation: Effects on Function and Focal Perfusion in Acute and Subacute Stroke , 2003, Cerebrovascular Diseases.
[29] Jun Chen,et al. Programmed Cell Death in Cerebral Ischemia , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[30] B. Siesjö,et al. Thresholds in cerebral ischemia - the ischemic penumbra. , 1981, Stroke.
[31] G. Schlaug,et al. The ischemic penumbra: operationally defined by diffusion and perfusion MRI. , 1999, Neurology.
[32] Á. Chamorro. Role of Inflammation in Stroke and Atherothrombosis , 2004, Cerebrovascular Diseases.
[33] M. Moskowitz,et al. Synergistic protective effect of caspase inhibitors and bFGF against brain injury induced by transient focal ischaemia , 2001, British journal of pharmacology.
[34] M. Ross,et al. Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[35] John H. Zhang,et al. Dual effect of HBO on cerebral infarction in MCAO rats. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.
[36] J. Martí-Fàbregas,et al. Favorable Outcome of Ischemic Stroke in Patients Pretreated with Statins , 2004, Stroke.
[37] R. R. Smith,et al. Hyperbaric oxygen and cerebral infarction in the gerbil. , 1987, Surgical neurology.
[38] P. Stys,et al. Anoxic and Ischemic Injury of Myelinated Axons in CNS White Matter: From Mechanistic Concepts to Therapeutics , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[39] S. Warach,et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A Phase II MRI-Based 9-Hour Window Acute Stroke Thrombolysis Trial With Intravenous Desmoteplase , 2005, Stroke.
[40] D. Corbett,et al. Persistent Neuroprotection with Prolonged Postischemic Hypothermia in Adult Rats Subjected to Transient Middle Cerebral Artery Occlusion , 2000, Experimental Neurology.
[41] R. Silbergleit,et al. Neuroprotective effects of hyperbaric oxygen treatment in experimental focal cerebral ischemia are associated with reduced brain leukocyte myeloperoxidase activity , 2003, Brain Research.
[42] P. Adeleine,et al. Hyperbaric oxygen in the treatment of acute ischemic stroke. A double-blind pilot study. , 1995, Stroke.
[43] E. Lo,et al. Induction of Caspase-Mediated Cell Death by Matrix Metalloproteinases in Cerebral Endothelial Cells after Hypoxia—Reoxygenation , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[44] A E Hillis,et al. Restoring blood pressure reperfused Wernicke’s area and improved language , 2001, Neurology.
[45] S. Mayer,et al. Effect of Prior Statin Use on Functional Outcome and Delayed Vasospasm after Acute Aneurysmal Subarachnoid Hemorrhage: A Matched Controlled Cohort Study , 2005, Neurosurgery.
[46] F. Nicoletti,et al. Metabotropic Glutamate Receptor Subtypes as Targets for Neuroprotective Drugs , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[47] Günther Deuschl,et al. Therapeutic Window for Use of Hyperbaric Oxygenation in Focal Transient Ischemia in Rats , 2004, Stroke.
[48] Klaas Nicolay,et al. Correlation between tissue depolarizations and damage in focal ischemic rat brain 1 Published on the World Wide Web on 12 July 1999. 1 , 1999, Brain Research.
[49] D. W. Beck,et al. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. , 1982, Neurosurgery.
[50] John Whitehead,et al. Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial , 2000, The Lancet.
[51] P. Lyden,et al. Synergistic Combinatorial Stroke Therapy: A Quantal Bioassay of a GABA Agonist and a Glutamate Antagonist , 2000, Experimental Neurology.
[52] K. Asplund,et al. Does Pretreatment With Statins Improve Clinical Outcome After Stroke?: A Pilot Case-Referent Study , 2001, Stroke.
[53] B. Lin,et al. Detection of Free Radical Activity During Transient Global Ischemia and Recirculation: Effects of Intraischemic Brain Temperature Modulation , 1995, Journal of neurochemistry.
[54] Thomas Benner,et al. A Pilot Study of Normobaric Oxygen Therapy in Acute Ischemic Stroke , 2005, Stroke.
[55] P. Bernardi,et al. A mitochondrial perspective on cell death. , 2001, Trends in biochemical sciences.
[56] M. Fisher,et al. A glycine site antagonist ZD9379 reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion. , 2000, Acta neurochirurgica. Supplement.
[57] G. Mies,et al. Repeated Negative DC Deflections in Rat Cortex following Middle Cerebral Artery Occlusion are Abolished by MK-801: Effect on Volume of Ischemic Injury , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[58] E. Lo,et al. Normobaric hyperoxia extends the reperfusion window in focal cerebral ischemia , 2005, Annals of neurology.
[59] W. Hacke,et al. Tolerability of NXY-059 at Higher Target Concentrations in Patients With Acute Stroke , 2003, Stroke.
[60] Tatsuro Mori,et al. Effects of Normobaric Hyperoxia in a Rat Model of Focal Cerebral Ischemia—Reperfusion , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[61] B. Cheung,et al. Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes. , 2004, British journal of clinical pharmacology.
[62] M. A. Jacobs,et al. Perfusion-weighted MRI as a marker of response to treatment in acute and subacute stroke , 2004, Neuroradiology.
[63] S. Lipton,et al. Excitotoxins in Neuronal Apoptosis and Necrosis , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[64] K. Takakura,et al. Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group. , 1998, Stroke.
[65] Stephen Rose,et al. Diffusion‐ and perfusion‐weighted MRI response to thrombolysis in stroke , 2002, Annals of neurology.
[66] D. J. Cole,et al. Focal Cerebral Ischemia in Rats: Effects of Induced Hypertension, during Reperfusion, on CBF , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[67] Jean-Philippe Thiran,et al. Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients , 2002, Annals of neurology.
[68] Seong-Gi Kim,et al. Effect of hyperoxia, hypercapnia, and hypoxia on cerebral interstitial oxygen tension and cerebral blood flow , 2001, Magnetic resonance in medicine.
[69] U. Laufs,et al. Pleiotropic effects of statins. - Basic research and clinical perspectives -. , 2010, Circulation journal : official journal of the Japanese Circulation Society.
[70] N. Plesnila,et al. Caspase activation and neuroprotection in caspase-3- deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[71] R. Busto,et al. Lipid Peroxidation In Vivo Induced by Reversible Global Ischemia in Rat Brain , 1984, Journal of neurochemistry.
[72] Enlimomab Acute Stroke Trial Investigators. Use of anti-ICAM-1 therapy in ischemic stroke , 2001, Neurology.
[73] K. Arai,et al. Lipoprotein receptor–mediated induction of matrix metalloproteinase by tissue plasminogen activator , 2003, Nature Medicine.
[74] T. Olsen,et al. Feasibility and Safety of Inducing Modest Hypothermia in Awake Patients With Acute Stroke Through Surface Cooling: A Case-Control Study: The Copenhagen Stroke Study , 2000, Stroke.
[75] C. Edenius,et al. Pharmacokinetics in renally impaired subjects of NXY-059, a nitrone-based, free-radical trapping agent developed for the treatment of acute stroke , 2002, European Journal of Clinical Pharmacology.
[76] Fuhai Li,et al. Synergistic effects of a combination of low-dose basic fibroblast growth factor and citicoline after temporary experimental focal ischemia. , 1999, Stroke.
[77] W. Koroshetz,et al. SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage , 2005, Neurology.
[78] M. Endres,et al. Withdrawal of Statin Treatment Abrogates Stroke Protection in Mice , 2003, Stroke.
[79] P. Nicotera,et al. Energy Requirement for Caspase Activation and Neuronal Cell Death , 2000, Brain pathology.
[80] T. Oury,et al. Mice overexpressing extracellular superoxide dismutase have increased resistance to focal cerebral ischemia , 1999, Neuroscience.
[81] L. Wilkins. Clinical Trial of Nimodipine in Acute Ischemic Stroke , 1992 .
[82] J. Seylaz,et al. Reduction of Infarct Volume by Magnesium after Middle Cerebral Artery Occlusion in Rats , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[83] J. Zivin,et al. Tissue plasminogen activator plus glutamate antagonist improves outcome after embolic stroke. , 1991, Archives of neurology.
[84] A Gregory Sorensen,et al. Assessing tissue viability with MR diffusion and perfusion imaging. , 2003, AJNR. American journal of neuroradiology.
[85] Fangyi Zhang,et al. Delayed Reduction of Ischemic Brain Injury and Neurological Deficits in Mice Lacking the Inducible Nitric Oxide Synthase Gene , 1997, The Journal of Neuroscience.
[86] N. Noshita,et al. Manganese Superoxide Dismutase Deficiency Exacerbates Cerebral Infarction After Focal Cerebral Ischemia/Reperfusion in Mice: Implications for the Production and Role of Superoxide Radicals , 2002, Stroke.
[87] John H. Zhang,et al. Effect of hyperbaric oxygen on apoptosis in neonatal hypoxia-ischemia rat model. , 2003, Journal of applied physiology.
[88] P. Lyden,et al. The Clomethiazole Acute Stroke Study in tissue-type plasminogen activator–treated stroke (CLASS-T) , 2001, Neurology.
[89] Guido Kroemer,et al. Mitochondrial control of cell death , 2000, Nature Medicine.
[90] S. Heiland,et al. Hyperbaric oxygen induces rapid protection against focal cerebral ischemia , 2005, Brain Research.
[91] N. Lassen,et al. TREATMENT OF FOCAL CEREBRAL ISCHEMIA WITH HYPERBARIC OXYGEN , 1964 .
[92] G. Feuerstein,et al. Inflammation and Stroke: Putative Role for Cytokines, Adhesion Molecules and iNOS in Brain Response to Ischemia , 2000, Brain pathology.
[93] A. Cross,et al. Effect of NXY‐059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window , 2002, British journal of pharmacology.
[94] C. Sommer,et al. Neuroprotection by Hyperbaric Oxygenation After Experimental Focal Cerebral Ischemia Monitored by MRI , 2004, Stroke.
[95] M. Moskowitz,et al. Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. , 2001, Stroke.
[96] L Persson,et al. The Effect of MK-801 on Cortical Spreading Depression in the Penumbral Zone following Focal Ischaemia in the Rat , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[97] Michael Holzer,et al. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest , 2002 .
[98] G. Fiskum. Mitochondrial participation in ischemic and traumatic neural cell death. , 2000, Journal of neurotrauma.
[99] R. Crowell,et al. Beneficial effects of induced hypertension on experimental stroke in awake monkeys. , 1984, Journal of neurosurgery.
[100] N. Wahlgren,et al. Clomethiazole Acute Stroke Study (CLASS) Results of a Randomized, Controlled Trial of Clomethiazole Versus Placebo in 1360 Acute Stroke Patients , 1998 .
[101] A. Shuaib,et al. Enhanced neuroprotection and reduced hemorrhagic incidence in focal cerebral ischemia of rat by low dose combination therapy of urokinase and topiramate , 2000, Neuropharmacology.
[102] F. Jöbsis,et al. Oxidation of cerebral cytochrome aa3 by oxygen plus carbon dioxide at hyperbaric pressures. , 1977, Journal of applied physiology: respiratory, environmental and exercise physiology.
[103] J. Wettstein,et al. White matter ischaemia , 1999, Brain Research Reviews.
[104] R. Ridley,et al. NXY-059, a Free Radical–Trapping Agent, Substantially Lessens the Functional Disability Resulting From Cerebral Ischemia in a Primate Species , 2001, Stroke.
[105] G. Boysen,et al. Enhancing the efficacy of thrombolysis by AMPA receptor blockade with NBQX in a rat embolic stroke model , 1993, Journal of the Neurological Sciences.
[106] F. Buonanno,et al. Pharmacological elevation of blood pressure in acute stroke. Clinical effects and safety. , 1997, Stroke.
[107] M. Moskowitz,et al. tPA and proteolysis in the neurovascular unit. , 2004, Stroke.
[108] E. Lo,et al. Extracellular proteolytic pathophysiology in the neurovascular unit after stroke , 2004, Neurological research.
[109] K. Lees,et al. Tolerability and Pharmacokinetics of the Nitrone NXY-059 in Patients With Acute Stroke , 2001, Stroke.
[110] R. Giffard,et al. Influence of Mild Hypothermia on Inducible Nitric Oxide Synthase Expression and Reactive Nitrogen Production in Experimental Stroke and Inflammation , 2002, The Journal of Neuroscience.
[111] M. Chopp,et al. Journal of Cerebral Blood Flow and Metabolism Temperature Modulation of Cerebral Depolarization during Focal Cerebral Ischemia in Rats: Correlation with Ischemic Injury , 2022 .
[112] M. Moskowitz,et al. Attenuated Neurotransmitter Release and Spreading Depression-Like Depolarizations after Focal Ischemia in Mutant Mice with Disrupted Type I Nitric Oxide Synthase Gene , 1998, The Journal of Neuroscience.
[113] Sandra E. Ford,et al. A pilot study of hyperbaric oxygen in the treatment of human stroke. , 1991, Stroke.
[114] S. Bernard,et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. , 2002, The New England journal of medicine.
[115] P. Lapchak,et al. Effects of the Spin Trap Agent Disodium- [tert-butylimino)methyl]benzene-1,3-disulfonate N-Oxide (Generic NXY-059) on Intracerebral Hemorrhage in a Rabbit Large Clot Embolic Stroke Model: Combination Studies With Tissue Plasminogen Activator , 2002, Stroke.
[116] F. Barone,et al. Inflammatory Mediators and Stroke: New Opportunities for Novel Therapeutics , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[117] G L Wolf,et al. Assessment of cerebral perfusion and arterial anatomy in hyperacute stroke with three-dimensional functional CT: early clinical results. , 1998, AJNR. American journal of neuroradiology.
[118] H. Diener,et al. Selfotel in acute ischemic stroke : possible neurotoxic effects of an NMDA antagonist. , 2000, Stroke.
[119] T. Wieloch,et al. Hypothermia Prevents the Ischemia‐Induced Translocation and Inhibition of Protein Kinase C in the Rat Striatum , 1991, Journal of neurochemistry.
[120] N. Rothwell,et al. Role of IL-1α and IL-1β in Ischemic Brain Damage , 2001, The Journal of Neuroscience.
[121] Profiles of glutamate and GABA efflux in core versus peripheral zones of focal cerebral ischemia in mice , 2001, Neuroscience Letters.
[122] D. Newell,et al. Combination Therapy with MK-801 and α-Phenyl-tert-butyl-nitrone Enhances Protection against Ischemic Neuronal Damage in Organotypic Hippocampal Slice Cultures , 1996, Experimental Neurology.
[123] R. Auer,et al. Eubaric hyperoxemia and experimental cerebral infarction , 2002, Annals of neurology.
[124] J. Grotta. Combination Therapy Stroke Trial: Recombinant Tissue-Type Plasminogen Activator with/without Lubeluzole , 2001, Cerebrovascular Diseases.
[125] F. Tortella,et al. Delayed Secondary Phase of Peri-Infarct Depolarizations after Focal Cerebral Ischemia: Relation to Infarct Growth and Neuroprotection , 2003, The Journal of Neuroscience.
[126] P. Weinstein,et al. Results of hyperbaric oxygen therapy during temporary middle cerebral artery occlusion in unanesthetized cats. , 1987, Neurosurgery.
[127] D. Tanné,et al. Soluble Intercellular Adhesion Molecule-1 and Risk of Future Ischemic Stroke: A Nested Case-Control Study From the Bezafibrate Infarction Prevention (BIP) Study Cohort , 2002, Stroke.
[128] G. Boysen,et al. Effects of citicoline combined with thrombolytic therapy in a rat embolic stroke model. , 1999, Stroke.
[129] J. Alger,et al. Beyond Mismatch: Evolving Paradigms in Imaging the Ischemic Penumbra With Multimodal Magnetic Resonance Imaging , 2003, Stroke.
[130] I. Herr,et al. CD95 Ligand (Fas-L/APO-1L) and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Mediate Ischemia-Induced Apoptosis in Neurons , 1999, The Journal of Neuroscience.
[131] K. Liu,et al. Interstitial pO2 in Ischemic Penumbra and Core are Differentially Affected following Transient Focal Cerebral Ischemia in Rats , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[132] K. Welch. Primer on cerebrovascular diseases , 1997 .
[133] R. Morrison,et al. bFGF enhances the protective effects of MK-801 against ischemic neuronal injury in vitro. , 1996, Neuroreport.
[134] K. Lees,et al. A randomized, double-blind, placebo-controlled pilot trial of intravenous magnesium sulfate in acute stroke. , 1995, Stroke.
[135] E. Lo,et al. Reduction of Tissue Plasminogen Activator-Induced Hemorrhage and Brain Injury by Free Radical Spin Trapping after Embolic Focal Cerebral Ischemia in Rats , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[136] E. Mackenzie,et al. Normobaric Hypoxia Induces Tolerance to Focal Permanent Cerebral Ischemia in Association with an Increased Expression of Hypoxia-Inducible Factor-1 and its Target Genes, Erythropoietin and VEGF, in the Adult Mouse Brain , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[137] Junying Yuan,et al. Apoptosis in the nervous system , 2000, Nature.
[138] I. Ford,et al. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial , 2004, The Lancet.
[139] R. Bullock,et al. Increased inspired oxygen concentration as a factor in improved brain tissue oxygenation and tissue lactate levels after severe human head injury. , 1999, Journal of neurosurgery.
[140] L. Goldstein,et al. Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial. , 2001, JAMA.
[141] Weizhao Zhao,et al. Albumin Therapy of Transient Focal Cerebral Ischemia: In Vivo Analysis of Dynamic Microvascular Responses , 2002, Stroke.
[142] D. Krieger,et al. Cooling for Acute Ischemic Brain Damage (COOL AID): An Open Pilot Study of Induced Hypothermia in Acute Ischemic Stroke , 2001, Stroke.
[143] Jae-Chang Jung,et al. Mitogen-Activated Protein Kinase Inhibition in Traumatic Brain Injury: In Vitro and In Vivo Effects , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[144] C. Epstein,et al. Reduction of CuZn-Superoxide Dismutase Activity Exacerbates Neuronal Cell Injury and Edema Formation after Transient Focal Cerebral Ischemia , 1997, The Journal of Neuroscience.
[145] Fuhai Li,et al. Synergistic effects of citicoline and MK-801 in temporary experimental focal ischemia in rats. , 1997, Stroke.
[146] H. Reulen,et al. Neuroprotective efficacy of combination therapy with two different antioxidants in rats subjected to transient focal ischemia , 1999, Brain Research.
[147] G. Salvesen. A lysosomal protease enters the death scene. , 2001, The Journal of clinical investigation.
[148] K. Sunami,et al. Hyperbaric oxygen reduces infarct volume in rats by increasing oxygen supply to the ischemic periphery , 2000, Critical care medicine.
[149] M. Müllner,et al. Effect of pretreatment with statins on the severity of acute ischemic cerebrovascular events , 2004, Journal of the Neurological Sciences.
[150] D. Stein,et al. Mild hypothermia: therapeutic window after experimental cerebral ischemia. , 1996, Neurosurgery.
[151] R. Sacco,et al. Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality , 2005, Neurology.
[152] B. Kristal,et al. An obligate role for oxygen in the early stages of glutamate-induced, delayed neuronal death , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[153] E. Tremoli,et al. Treatment With Statins After Induction of Focal Ischemia in Rats Reduces the Extent of Brain Damage , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[154] M. Biros,et al. Effects of hyperbaric oxygenation therapy on cerebral metabolism and intracranial pressure in severely brain injured patients. , 2001, Journal of neurosurgery.
[155] H. Diener,et al. Organization of Stroke Care: Education, Referral, Emergency Management and Imaging, Stroke Units and Rehabilitation , 2003, Cerebrovascular Diseases.
[156] R. Ridley,et al. Functional and histological evidence for the protective effect of NXY-059 in a primate model of stroke when given 4 hours after occlusion. , 2003, Stroke.
[157] M. Fisher. Recommendations for Advancing Development of Acute Stroke Therapies: Stroke Therapy Academic Industry Roundtable 3 , 2003, Stroke.
[158] M. Kirk,et al. Hyperbaric Oxygen Therapy in Acute Ischemic Stroke: Results of the Hyperbaric Oxygen in Acute Ischemic Stroke Trial Pilot Study , 2003, Stroke.
[159] P. Ridker,et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. , 2000, The New England journal of medicine.
[160] A. Buchan,et al. NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat , 2001, Brain Research.
[161] Gary Duckwiler,et al. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging , 2000, Annals of neurology.
[163] R. Sobel,et al. Mild Hypothermia Inhibits Nuclear Factor-κB Translocation in Experimental Stroke , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[164] Joseph P. Broderick,et al. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .
[165] Robert M Friedlander,et al. Apoptosis and caspases in neurodegenerative diseases. , 2003, The New England journal of medicine.
[166] M. Ginsberg. Hypothermic Neuroprotection in Cerebral Ischemia , 1997 .
[167] M. Fisher,et al. New perspectives on developing acute stroke therapy , 2003, Annals of neurology.
[168] S. Warach,et al. Rising statin use and effect on ischemic stroke outcome , 2004, BMC medicine.
[169] S. Warach,et al. Magnetic Resonance Imaging of Acute Stroke , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[170] D. Atochin,et al. Tissue Plasminogen Activator Promotes Matrix Metalloproteinase-9 Upregulation After Focal Cerebral Ischemia , 2005, Stroke.
[171] M. Endres,et al. Atorvastatin Upregulates Type III Nitric Oxide Synthase in Thrombocytes, Decreases Platelet Activation, and Protects From Cerebral Ischemia in Normocholesterolemic Mice , 2000, Stroke.
[172] C. Epstein,et al. Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[173] J. Toole,et al. Hyperbaric oxygen decreases infarct size and behavioral deficit after transient focal cerebral ischemia in rats , 2000, Brain Research.
[174] Jeffrey L. Saver,et al. Prehospital Neuroprotective Therapy for Acute Stroke: Results of the Field Administration of Stroke Therapy–Magnesium (FAST–MAG) Pilot Trial , 2004, Stroke.
[175] R. Rothlein,et al. Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy , 1995, Neurology.
[176] R. Harbaugh,et al. Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia. , 1996, Journal of neurosurgery.
[177] C. Prosser,et al. COMPARATIVE ANIMAL PHYSIOLOGY , 1962 .
[178] J. Thiran,et al. Comparison of Admission Perfusion Computed Tomography and Qualitative Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging in Acute Stroke Patients , 2002, Stroke.
[179] R. Sacco,et al. Tumor Necrosis Factor Receptor Levels Are Associated With Carotid Atherosclerosis , 2002, Stroke.
[180] M. Moskowitz,et al. Synergistic effects of caspase inhibitors and MK‐801 in brain injury after transient focal cerebral ischaemia in mice , 1998, British journal of pharmacology.
[181] Rick M Dijkhuizen,et al. Normobaric hyperoxia reduces MRI diffusion abnormalities and infarct size in experimental stroke , 2002, Neurology.
[182] P. Lapchak,et al. Coadministration of NXY-059 and tenecteplase six hours following embolic strokes in rabbits improves clinical rating scores , 2004, Experimental Neurology.
[183] H. Nawashiro,et al. Preferential Conditions for and Possible Mechanisms of Induction of Ischemic Tolerance by Repeated Hyperbaric Oxygenation in Gerbil Hippocampus , 2001, Neurosurgery.
[184] K. Furie,et al. Mechanisms of Hemorrhagic Transformation After Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke , 2004, Stroke.
[185] P. Lyden,et al. Effects of hyperbaric oxygen on neurologic outcome for cerebral ischemia in rats. , 1998, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[186] S. Lipton,et al. Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[187] J. Ritter. Clinical trial of nimodipine in acute ischemic stroke. The American Nimodipine Study Group. , 1992, Stroke.
[188] R. Sacco,et al. Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial. , 2001, JAMA.
[189] M. Moskowitz,et al. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. , 1994, Science.
[190] C. Maier,et al. Mild hypothermia reduces ICAM-1 expression, neutrophil infiltration and microglia/monocyte accumulation following experimental stroke , 2002, Neuroscience.
[191] W. Hacke,et al. Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. , 1998, Stroke.
[192] E. Lo,et al. Junctional complexes of the blood–brain barrier: permeability changes in neuroinflammation , 2002, Progress in Neurobiology.